2011 Workshop report – Visualising benefit risk
Visualising benefit risk: The key to developing a framework that informs stakeholder perspective and clarity of decision making 16-17th June 2011, Washington DC, USA In 2010 CIRS held its [...]
2011 Workshop report – Evidentiary requirements in clinical development
Evidentiary requirements in clinical development: Synchronising phase 3 requirements to meet multiple needs 31st March - 1st April 2011, Geneva, Switzerland A drug development programme is by its very [...]
2011 Workshop report – Regional alignment in Asia Pacific
Regional alignment in Asia Pacific: What needs to be in the regulatory science toolkit to enable good regulatory decision making? 26-27th January 2011, Tokyo, Japan Regulatory agencies are rising [...]
2010 Workshop report – New development paradigms to facilitate early access
New development paradigms: Building regulatory confidence for the early release of medicines 11-12th October 2010, Surrey, UK Over the last 5 years CIRS workshops have suggested a number of [...]
2010 Executive Forum report – Refining the benefit-risk framework for the assessment of medicines
Refining the benefit-risk framework for the assessment of medicines: Valuing and weighting benefit and risk parameters 17-18th June 2010, Washington DC, USA Determining the benefit-risk balance of a medicine [...]
2010 Workshop report – Review and reimbursement: Aligning the needs and requirements in clinical development
Review and reimbursement: Aligning the needs and requirements in clinical development 23rd-24th March 2010, Washington DC, USA The current dynamics of bringing new medicines to market are being influenced [...]
2009 Workshop Report – Acceptability of data generated from foreign clinical trials and ethnic factors in drug development
This CIRS multi-stakeholder workshop examined strategies for incentivising the development of medicines for common chronic diseases.
2009 Workshop report – Review and reimbursement: A special case for better co-operation
Review and reimbursement: A special case for better co-operation 29-30th September 2009, Surrey, UK The current dynamics of bringing new medicines to market are influenced by potential conflicts between [...]
2009 Workshop report – Strategies for communicating benefits and risks to decision makers
Strategies for communicating benefits and risks to decision makers: Explaining methods, findings and conclusions through a common language approach 17-19th June 2009, Washington DC, USA Determining the benefit-risk (BR) [...]
2009 Workshop report – Expediting patients’ access to medicines: Solutions to simultaneous submissions and approvals
Expediting patients' access to medicines: Solutions to simultaneous submissions and approvals 20-31 March 2009, Surrey, UK Major companies engaging in global development programmes are currently trying to reduce the [...]